South Africa is currently in negotiations with Gilead Sciences to establish local production of a new HIV therapy called lenacapavir. This therapy, which is administered twice...
A coalition of healthcare professionals in Canada has announced new guidelines aimed at expanding access to medications that prevent HIV infection. The Canadian Medical Association released...
Researchers at Western University and the University of Calgary have made significant strides in understanding how HIV persists in the body. Their study reveals that the...
The Prairie Mountain Health region in Manitoba has experienced a dramatic rise in HIV cases, escalating from just six reported cases in 2022 to a staggering...
The World Health Organization (WHO) has officially recommended Gilead Sciences’ newly approved HIV pre-exposure prophylaxis (PrEP) medication, Yeztugo (lenacapavir). This endorsement follows its approval by the...
